<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-F5KB3I7Y</identifier><date>1990</date><creator>Bobnar, Albina</creator><relation>documents/doc/F/URN_NBN_SI_doc-F5KB3I7Y_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-F5KB3I7Y_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 25-28</format><identifier identifier_type="COBISSID_HOST">2708075</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-F5KB3I7Y</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Maligni melanom</source><rights>InC</rights><subject language_type_id="slv">Antineoplastic agents, combined</subject><subject language_type_id="slv">Immunotherapy</subject><subject language_type_id="slv">Melanoma</subject><subject language_type_id="slv">Neoplasm staging</subject><subject language_type_id="slv">Nursing care</subject><subject language_type_id="slv">Radiotherapy</subject><subject language_type_id="slv">Skin neoplasms</subject><subject language_type_id="slv">Surgery</subject><subject language_type_id="slv">Survival</subject><title>Zdravstvena nega bolnika, zdravljenega z imunomodulatorji in kemoterapevtiki</title></Record>